BIOMAT Database Logo BIOMAT Database Logo

Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. 1996

J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Department of Veterinary Pathology, Glasgow, UK.

Prophylactic vaccination of cattle with the N terminus (L2a, aa 11-200) of the minor capsid protein L2 completely prevented bovine papillomavirus type 4 (BPV-4) infection of the alimentary canal. To investigate the mechanisms underlying protection from viral infection, sera from vaccinated animals were analysed in neutralization assays both in the nude mouse xenograft system and in cattle. BPV-4 retained its infectivity when incubated with preimmune cattle sera, whereas, when incubated with immune sera from animals vaccinated with either whole L2 or its N terminus L2a, its infectivity was greatly reduced, indicating that the immune sera had neutralizing activity against the virus. This activity could be abrogated by absorbing the immune sera with L2 or L2a, thus indicating that virus neutralization was due to the presence in the immune sera of anti-L2 antibodies.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.
August 1995, Virology,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies.
March 2010, Journal of translational medicine,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.
October 1998, Journal of virology,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
May 2008, Journal of virology,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.
April 1999, Vaccine,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection.
March 1999, Virology,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Complement-requiring neutralizing antibodies in cattle to infectious bovine rhinotracheitis virus.
January 1974, Archiv fur die gesamte Virusforschung,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
DNA vaccination of mice with plasmid expressing human papillomavirus 6 major capsid protein L1 elicits type-specific antibodies neutralizing pseudovirions constructed in vitro.
February 2000, Journal of medical virology,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4.
January 1997, Research in veterinary science,
J M Gaukroger, and L M Chandrachud, and B W O'Neil, and G J Grindlay, and G Knowles, and M S Campo
Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.
July 2010, Journal of virological methods,
Copied contents to your clipboard!